| Mrs Hannah Prather, | |
|
4880 Ne Goodview Cir, Lees Summit, MO 64064-1996 | |
| (816) 478-3008 | |
| Not Available |
| Full Name | Mrs Hannah Prather |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 4880 Ne Goodview Cir, Lees Summit, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427402767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Provider Name | St Lukes Hospital Of Kansas City |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063494177 PECOS PAC ID: 9436060084 Enrollment ID: O20031112000506 |
News Archive
Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program research collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd..
The Spine Patient Outcomes Research Trial (SPORT) is the first comprehensive study to look at the effectiveness of different treatments for low back and leg pain. It was designed to provide data and outcomes to guide doctors and their patients in their treatment choices for three common spinal disorders: intervertebral disk herniation (IDH), degenerative spondylolisthesis (DS), and lumbar spinal stenosis (LSS).
Some states are not considering the symptoms that brought the patients to the hospital, the doctors charge. In other Medicaid news, Texas is looking at several options for Medicaid reform, Pennsylvania looks at human service program cuts, Wisconsin Democrats seek to stop reductions there and Minnesota officials respond to criticism from Sen. Charles Grassley.
A new intervention, the result of a collaboration between researchers from the University of Haifa, City University of New York and Indiana University, was found to reduce the self-stigma and improve the quality of life and self-esteem among persons with serious mental illness.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange announced today that it has commenced patient enrolment in a phase 2/3 clinical trial of CF101 for the treatment of Psoriasis.
› Verified 3 days ago
| Provider Name | Mid America Balance Institute Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1346412376 PECOS PAC ID: 9931271335 Enrollment ID: O20181217001274 |
News Archive
Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program research collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd..
The Spine Patient Outcomes Research Trial (SPORT) is the first comprehensive study to look at the effectiveness of different treatments for low back and leg pain. It was designed to provide data and outcomes to guide doctors and their patients in their treatment choices for three common spinal disorders: intervertebral disk herniation (IDH), degenerative spondylolisthesis (DS), and lumbar spinal stenosis (LSS).
Some states are not considering the symptoms that brought the patients to the hospital, the doctors charge. In other Medicaid news, Texas is looking at several options for Medicaid reform, Pennsylvania looks at human service program cuts, Wisconsin Democrats seek to stop reductions there and Minnesota officials respond to criticism from Sen. Charles Grassley.
A new intervention, the result of a collaboration between researchers from the University of Haifa, City University of New York and Indiana University, was found to reduce the self-stigma and improve the quality of life and self-esteem among persons with serious mental illness.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange announced today that it has commenced patient enrolment in a phase 2/3 clinical trial of CF101 for the treatment of Psoriasis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Hannah Prather, 4880 Ne Goodview Cir, Lees Summit, MO 64064-1996 Ph: () - | Mrs Hannah Prather, 4880 Ne Goodview Cir, Lees Summit, MO 64064-1996 Ph: (816) 478-3008 |
News Archive
Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program research collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd..
The Spine Patient Outcomes Research Trial (SPORT) is the first comprehensive study to look at the effectiveness of different treatments for low back and leg pain. It was designed to provide data and outcomes to guide doctors and their patients in their treatment choices for three common spinal disorders: intervertebral disk herniation (IDH), degenerative spondylolisthesis (DS), and lumbar spinal stenosis (LSS).
Some states are not considering the symptoms that brought the patients to the hospital, the doctors charge. In other Medicaid news, Texas is looking at several options for Medicaid reform, Pennsylvania looks at human service program cuts, Wisconsin Democrats seek to stop reductions there and Minnesota officials respond to criticism from Sen. Charles Grassley.
A new intervention, the result of a collaboration between researchers from the University of Haifa, City University of New York and Indiana University, was found to reduce the self-stigma and improve the quality of life and self-esteem among persons with serious mental illness.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange announced today that it has commenced patient enrolment in a phase 2/3 clinical trial of CF101 for the treatment of Psoriasis.
› Verified 3 days ago
Anna Grashoff, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 4880 Ne Goodview Cir, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-875-2597 | |
Amy Marie Lane, M.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4200 Ne Suwannee Dr, Lees Summit, MO 64064 Phone: 816-686-7708 | |
Allison Peter, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 4880 Ne Goodview Cir, Lees Summit, MO 64064 Phone: 816-478-3008 | |
Heidi Frazier, MSCCCA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4880 Ne Goodview Circle, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-0507 | |
Karli E Reichert, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 458 Ne State Route 291, Lees Summit, MO 64086 Phone: 816-507-8885 Fax: 816-533-4344 | |
Marli Sims, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 458 Ne 291 Hwy, Lees Summit, MO 64086 Phone: 816-507-8885 Fax: 816-533-4344 | |
Shawn N Mcclure, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 320 Nw Victoria Dr, Lees Summit, MO 64086 Phone: 816-265-6150 |